Your browser doesn't support javascript.
loading
B-cell haematological malignancies and SARS-CoV-2 infection: Could immunological interventions influence the outcome?
Ochoa-Grullón, Juliana; Peña Cortijo, Ascensión; Guevara-Hoyer, Kissy; Jiménez García, Carlos; de la Fuente, Eduardo; de la Peña, Antonia Rodríguez; Fernández-Arquero, Miguel; González Fernández, Ata; Sánchez-Ramón, Silvia.
Afiliación
  • Ochoa-Grullón J; Department of Clinical Immunology and IdISSC Hospital Clínico San Carlos Madrid Spain.
  • Peña Cortijo A; Department of Immunology Ophthalmology and Otorhinolaryngology (IOO) Complutense University School of Medicine Madrid Spain.
  • Guevara-Hoyer K; Department of Haematology Complutense University School of Medicine Madrid Spain.
  • Jiménez García C; Department of Clinical Immunology and IdISSC Hospital Clínico San Carlos Madrid Spain.
  • de la Fuente E; Department of Immunology Ophthalmology and Otorhinolaryngology (IOO) Complutense University School of Medicine Madrid Spain.
  • de la Peña AR; Department of Clinical Immunology and IdISSC Hospital Clínico San Carlos Madrid Spain.
  • Fernández-Arquero M; Department of Clinical Immunology and IdISSC Hospital Clínico San Carlos Madrid Spain.
  • González Fernández A; Department of Immunology Ophthalmology and Otorhinolaryngology (IOO) Complutense University School of Medicine Madrid Spain.
  • Sánchez-Ramón S; Department of Clinical Immunology and IdISSC Hospital Clínico San Carlos Madrid Spain.
EJHaem ; 2(3): 503-507, 2021 Aug.
Article en En | MEDLINE | ID: mdl-34518828

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article